Seminar Invitation: Pitfalls for SMEs in protecting and claiming incentives for new developments

Presented by:

  • Craig Humphris (Wrays)Wrays
  • Mark Jeffreson (UHY Haines Norton)
  • David Greatwich (Swanson Reed)

Join Swanson Reed, UHY Haines Norton and Wrays for a practical workshop that will focus on the problems that every day companies face in protecting, and claiming incentives for their new products.

You will hear from three industry experts on a range of topics, including tax issues, R&D tax incentives and patent protection.

On conclusion of the presentation, participants will have an opportunity to ask the panel any specific questions in a friendly and constructive forum.

 

Time Presentation Presenter
8:30am – 9:00am: Session 1: Protecting Intellectual Property (IP) Craig Humphris
9:00am – 9:30am: Session 2: IP & Relevant Tax Considerations Mark Jeffreson
9:30am – 10:00am: Session 3: R&D Tax Incentives David Greatwich
10:00am – 10:30am: Session 4: Panel Q&A and Networking Opportunity

 

Craig Humphris Mark Jeffreson David Greatwich
Craig_Humphris Mark_Jeffreson David Greatwich
 View Craig’s bio  View Mark’s bio  View David’s bio

Adelaide Seminar:


View Larger Map

Wednesday, 18th June 2014
8:30am – 10:30am
Hilton Adelaide
233 Victoria Square
Adelaide, 5000

Cost: Free!
Register Before: Friday 13th June

 

Full attendance at this workshop will yield 2 CPE hours towards the Tax Practitioners Board’s (TPB) CPE requirements.

Contact Amy Nolan for more information:

Ph: 08 8121 7850
Mob: 0435 713 493

Are you Eligible to claim R&D? Take our R&D Eligibility Survey and find out.

Latest News

Telix Pharmaceuticals solidifies Australian Biotech Success, posting net profit after years of Refundable R&D Tax Offset Recipients

Melbourne-based Telix Pharmaceuticals has previously been one of the largest recipients of the R&D Tax incentive, and has continued its rare feat in Biotechnology; commercialising a product, and progressing to growth and profit. The company’s radiopharmaceuticals are designed to deliver focused doses of radiation with precision targeting via an injection, regardless of where the cancer or disease is in the body. In the early stages of Telix Pharmaceuticals, the company was receiving substantial refundable R&D Tax Offsets (including more than $12M […]

AusIndustry Information Sessions in September 2024

AusIndustry have announced they will be conducting a R&D Tax Incentive Registration webinar on Wednesday, 11 September. This webinar is aimed at small to medium businesses that already have a basic understanding of the R&D Tax Incentive program and notes that it will cover: How the registration process works; The types of information to include in your application; The importance of record keeping and the types of evidence you need to keep. Information for registration to attend the session is […]